Fumaric Acid

Fumaric Acid

SCHEMBL29802140

COc1ccc(CN2CCN(CCCSc3cc(C(C)(C)C)c(O)c(C(C)(C)C)c3)CC2)c(OC)c1OC.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 6/20 0.55
KMT2A known ✓ Q03164 6/20 0.55
CPT1B Q92523 1/20 0.86
TDP1 Q9NUW8 1/20 0.65
ALDH1A1 P00352 3/20 0.49
KDM4E B2RXH2 3/20 0.49
LMNA P02545 1/20 0.49
PKM P14618 1/20 0.44
CACNA1G O43497 1/20 0.44
CYP2C19 P33261 1/20 0.43
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2885813 0.93 CPT1B (1.00) CPT1BTDP1MEN1KMT2AALDH1A1
SCHEMBL9015998 0.89 CPT1B (0.93) CPT1BTDP1MEN1KMT2AALDH1A1
SCHEMBL9015962 0.80 CPT1B (0.75) CPT1BTDP1MEN1KMT2AALDH1A1
SCHEMBL9623027 0.79 CPT1B (0.74) CPT1BTDP1MEN1KMT2AALDH1A1
SCHEMBL9015995 0.79 CPT1B (0.74) CPT1BTDP1MEN1KMT2AALDH1A1
SCHEMBL9015960 0.78 CPT1B (0.73) CPT1BTDP1MEN1KMT2AALDH1A1
SCHEMBL9015980 0.78 CPT1B (0.73) CPT1BTDP1MEN1KMT2AALDH1A1
SCHEMBL9015974 0.78 CPT1B (0.73) CPT1BTDP1MEN1KMT2AALDH1A1
Fumaric Acid SCHEMBL9296210 0.77 MEN1 (0.54) CPT1BMEN1KMT2AALDH1A1KDM4E
Fumaric Acid SCHEMBL9296208 0.77 MEN1 (0.54) CPT1BMEN1KMT2AALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12133720-B2 Methods and compositions for restoring homeostatic capacity of a subject Palo Alto Investors LP (US) 2024-11-05 US disclosed
WO-2022190064-A1 METHODS FOR IDENTIFYING SUBJECTS WITH BETACORONAVIRUS INFECTIONS WHO ARE AT RISK OF ACUTE RESPIRATORY SYNDROME AND METHODS FOR THE TREATMENT OF SAME VEXO PHARMACEUTICALS DMCC (AE) 2022-09-15 WO disclosed